In view of the great influence of Taihe project of Yuekang Pharmaceutical Group in the domestic pharmaceutical industry, GPHL Baiyunshan Pharmaceutical Factory actively cooperated with it, and also selected a site in Taihe Economic Development Zone, investing 654.38+58 billion yuan to build a modern chemical production base of GPHL.
During the Twelfth Five-Year Plan period, the Development Zone will continue to pay equal attention to infrastructure and project development, vigorously implement the development strategy of industrial clusters, give play to the leading role of leading enterprises, build a pharmaceutical production base, and become an influential pharmaceutical capital. It is planned to introduce more than 300 pharmaceutical and supporting projects, and the industrial output value and sales revenue of the pharmaceutical industry will achieve "double 50 billion yuan".
The large-scale project-driven strategy in the field of pharmaceutical industry is a mirror of the development of leading industrial clusters in Taihe Economic Development Zone.
Introduce large projects and promote industrial development through the demonstration role of leading enterprises —— The oriental philosophy of "four to two thousand pounds" is vividly interpreted by Taihe Economic Development Zone.
At the same time, the development zone has extended from the original single pharmaceutical marketing and processing development to a relatively perfect industrial cluster integrating pharmaceutical machinery manufacturing, pharmaceutical packaging material production, medical information service and logistics distribution. At present, the pharmaceutical packaging enterprises that have been built or under construction include Renji Printing, Kang Hua Packaging, Yuan Jing Packaging and Huaxia Jiahe New Materials. Anhui Shen Jian Medical Equipment Co., Ltd. has modern processing and manufacturing equipment such as American plasma flame cutting machine, submerged arc welding machine, argon arc welding machine, vertical CNC lathe, large automatic plate bending machine and automatic welding machine, and more than 50 sets of high-precision processing equipment. Logistics projects include North Logistics, Zheng Da Logistics and World Warehouse Logistics. There are western medicine market, Chinese herbal medicine market and international health care products mall in the market. Established an industry guarantee company and a health care product chamber of commerce.
The content of medical science and technology is increasing. In the development of pharmaceutical industry, we attach great importance to the independent innovation and technological innovation of enterprises: Baker Pharmaceutical, Yifan Pharmaceutical, Hubble Pharmaceutical, Yuekang Nature, Poseidon Pharmaceutical, Mitsui Wansen Pharmaceutical, Lihai Pharmaceutical, Baohe Bio, etc. are all high-tech pharmaceutical enterprises. Among them, Baker Pharmaceuticals has the international leading chiral compound synthesis technology, Baohe Bio has a major breakthrough and patented technology in the extraction of traditional Chinese medicine, and the device for preparing 7-ACA by Yuekang Bio is currently the first in the world.
Actively develop the cultivation of pharmaceutical raw materials. On the basis of existing mint planting in Taihe, the government actively expanded the scale of mint planting, signed cooperation agreements with dozens of raw material planting bases such as Ruanqiao, Fentai and Li Xing, accelerated the construction of green GAP Chinese herbal medicine bases, and provided a strong source guarantee for the raw material demand of the pharmaceutical industry.
Accelerate the adjustment of industrial structure and vigorously promote project implementation and enterprise cultivation. First, introduce, develop and implement a number of key projects. Adhere to the introduction of foreign capital and the development of local enterprises, vigorously organize and implement a number of key projects of leading, base, flagship and tax sources for the industrialization of scientific research achievements, and accelerate the formation of high-quality project groups that support the leap-forward development of the pharmaceutical industry and have strong competitiveness. The second is to enhance the core competitiveness of key enterprises. Constantly expand the scale of enterprises, enhance core competitiveness, and cultivate a number of large enterprises with strong capital operation ability, strong technological innovation ability, strong market development ability, strong management ability and strong anti-risk ability. The third is to accelerate the development of a number of growth-oriented enterprises. Vigorously support chemical and biopharmaceutical enterprises and vigorously develop Chinese patent medicines. Give full play to the advantages of pharmaceutical business in Taihe county, vigorously develop the pharmaceutical industry, and attract well-known domestic pharmaceutical groups to develop the pharmaceutical processing industry. Encourage and support pharmaceutical enterprises to become bigger and stronger, rely on the rich production base and market advantages of medicinal materials in Taihe County, strengthen the close integration of Taihe western medicine market and Bozhou traditional Chinese medicine market, focus on the development of national first-and second-class new drugs and proprietary Chinese medicines, expand the scale of production and extraction of traditional Chinese medicines, increase product varieties, and expand the production scale of pharmaceutical industry. Fourth, through key support and orderly competition, promote the transformation of enterprise layout to clustering, production structure to division of labor and cooperation, product structure to characteristics, high quality and high added value, and cultivate a number of pharmaceutical enterprises with strong innovation ability, high management level and distinctive characteristics. Strengthen support and cultivation, and speed up the listing of Baker Pharmaceutical, Yuekang Pharmaceutical and Huayuan Renji Pharmaceutical.
Actively support high-tech industries. Accelerate the pace of scientific and technological innovation and high-tech industrialization, focus on biopharmaceuticals and pharmaceutical intermediates, vigorously develop modern biopharmaceuticals and biomedical materials, form a number of high-tech achievements with independent intellectual property rights and realize industrialization.
Actively develop related supporting industries and form pharmaceutical industrial clusters. Taking the existing large-scale pharmaceutical industry as the leader and focusing on the extraction, research and development and production of traditional Chinese medicine, we will build a pharmaceutical industrial park. Integrate the medical device manufacturing industry around the pharmaceutical industrial park, actively carry out foreign cooperation on the basis of existing medical device processing enterprises, and improve the technical level of medical device production; At the same time, actively build a modern circulation system, further enhance the added value of the pharmaceutical industry, speed up the construction of pharmaceutical storage bases and distribution centers, attract large-scale circulation enterprises and chain sellers at home and abroad to settle in, engage in large-scale operations, and achieve seamless docking with production enterprises. Strengthen the construction of pharmaceutical logistics industrial park, develop in an all-round way, combine with each other, and make every effort to build a modern pharmaceutical industrial cluster.
By virtue of its location advantages in the east-west junction and the transitional zone between the north and the south, adhering to the service concept of enthusiasm and honesty, and vigorously implementing the strategies of professional cluster, talent priority, system innovation and economy and intensification, Taihe Economic Development Zone, which is poised for development, is striding forward towards the goals of "China's medical and health industry capital", "China's important textile and garment manufacturing base" and "Central agricultural product deep processing base".
Zhaowei, director of the Management Committee of Taihe Economic Development Zone, said frankly that, like other development zones, objective factors such as land, capital and institutional mechanisms also restrict the rapid development of Taihe Economic Development Zone. However, compared with these objective factors, the lack of intellectual resources such as cutting-edge technology and high-level talents is the biggest shortcoming of the future industrial upgrading and transformation of the development zone.
Experts said that after years of development, Taihe Development Zone has shown its own development advantages and formed its own leading industry. No matter from the demand of its own development or from the macro-economic trend of accelerating transformation, the industrial upgrading and development transformation of Taihe Economic Development Zone is imperative.
"So our next step is to recruit talents. Today, capital is not the most important factor. Not only because of funds, but also because of talents and brains. " Zhao Wei had a plan for this.
The development zone is inviting top scholars and well-known experts from inside and outside the province to form a high-standard advisory group through various channels, and plans to introduce a group of high-level talents such as academicians and doctors to work in the zone by introducing leading domestic enterprises in various industries.
For example, Xu Kun, who founded Jinan Dexinjia Biotechnology Co., Ltd. in February 2007, is a doctor jointly trained by Shandong University and Osaka University. At present, the company has applied for 6 invention patents and approved 1. Among them, the patent of "synthesis of tiotropium bromide meeting EP standards" has been applied for patent protection in the United States, Britain, Japan, South Korea, India and Europe. At the same time, the company's application for "production of tiotropium bromide meeting EP standards" was approved by the National Innovation Fund 20 1 1. At present, the company has invested 250 million yuan to establish Anhui Dexinjia Biotechnology Co., Ltd. in the Biomedical Industrial Park of Taihe Economic Development Zone. After the project is put into production, the annual industrial output value will be 690 million yuan, and the profit and tax will be 90 million yuan.
Liu Xuebin, director of Guangzhou Baiyunshan Chemical Pharmaceutical Factory of Guangzhou Pharmaceutical Group, which is going to put into production in Taihe, is also an excellent doctoral student. In 2003, he invented "crystalline cefathiamidine and its manufacturing method" and obtained a patent.
"Not seeking, but seeking integration. We warmly welcome high-level talents at home and abroad who are willing to work in the development zone and try their best to provide good services for their work and life. "
During the "Twelfth Five-Year Plan" period, on the one hand, Taihe Economic Development Zone should enlarge and strengthen the traditional advantageous industries, attach importance to the development prospects, benefits and potential of industries, be good at grasping the relationship between the upper, middle and lower reaches of industries, take project settlement as the main direction of economic development in the Economic Development Zone, focus on introducing large-scale projects with investment of more than 100 million yuan, and promote industrial scale development through scientific and technological support, intellectual support and policy support.
On the other hand, Taihe Economic Development Zone will persist in promoting new industrialization and focus on cultivating industrial clusters. Focus on planning and building pharmaceutical industrial parks, cultivate and expand high-tech industries represented by biomedicine, guide and encourage park enterprises to strengthen independent innovation, enhance product market competitiveness, and strive to become well-known brands in the province and even the whole country.
20 12 is a crucial year for the development of the development zone, the expansion and upgrading of the region and the construction of provincial biomedical bases, and a milestone year for the development zone to achieve the goal of "double 50 billion" in industrial output value and commercial sales income of the pharmaceutical industry. Under the correct leadership of Taihe County Party Committee and county government, the whole region will strengthen confidence, seize opportunities, blaze new trails and make positive progress, and strive to promote the three civilizations in the development zone to go hand in hand, strive to be the leader of scientific development and bravely be the vanguard of the rise of northern Anhui.